Pms38 - Cost Effectiveness Analysis of Secukinumab Versus Ustekinumab for the Treatment of Psoriatic Arthritis in the United States
Year: 2018
Type: conference-abstract
Source: Value in Health
Authors: J. Bilal, T. Urbine, P.T. Saligrama, M.J. Khalil, D.C. Malone, S. Bhattacharjee
Institutions: University of Arizona, West Virginia University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2905983441
